Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2020 18:25 ET | Source: MannKind

MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference

WESTLAKE VILLAGE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
February 20, 2020 09:00 ET | Source: MannKind

MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)

WESTLAKE VILLAGE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza® (insulin human)...
February 18, 2020 09:00 ET | Source: MannKind

MannKind Corporation to Hold 2019 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2020

WESTLAKE VILLAGE, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2019 fourth quarter and full year financial results and its management will host a...
January 06, 2020 08:00 ET | Source: MannKind

Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month

WESTLAKE VILLAGE, Calif., Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A., has received written notice from the Chamber...
December 20, 2019 09:00 ET | Source: MannKind

Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza® Relative to Insulin Aspart in Type 1 Diabetes

WESTLAKE VILLAGE, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that Hypoglycemia is reduced with use of inhaled Technosphere® Insulin relative to...
November 29, 2019 09:00 ET | Source: MannKind

MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference

WESTLAKE VILLAGE, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
November 21, 2019 09:00 ET | Source: MannKind

MannKind Appoints Tony Hooper to Its Board of Directors

WESTLAKE VILLAGE, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020. Mr....
November 06, 2019 08:00 ET | Source: MannKind

MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results

3Q 2019 Total Revenues of $14.6 million; +227% vs. 3Q 2018° 3Q 2019 Afrezza Net Revenue was $6.4 million; +46% vs. 3Q 2018 • Afrezza sold to our marketing partner in Brazil for launch was $0.7...
November 04, 2019 09:00 ET | Source: MannKind

MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics

WESTLAKE VILLAGE, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its...
October 30, 2019 09:00 ET | Source: MannKind

MannKind Corporation to Hold 2019 Third Quarter Financial Results Conference Call on November 6, 2019

WESTLAKE VILLAGE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2019 third quarter and year-to-date financial results and its management will host a...